retatrutide weight loss clinical trial results Phase 3: TRIUMPH Program 2026 New Phase 3 retatrutide data

Single-cell transcriptome profiling of human pancreatic islets in health and type 2 diabetes

Education on the importance of good sleep hygiene should be provided as part of lifestyle counselling to patients on GLP-1 based therapy

Weight maintenance is individualized: some patients stop, some cycle back on, and others stay on a lower maintenance dose

Muscle mass and glucagon-like peptide-1 receptor agonists: Adaptive or maladaptive response to weight loss

Contact us today to discuss how we can support your dental health during your GLP-1 treatment journey

Retatrutide Efficacy: The Phase 2 obesity trial, published in the New England Journal of Medicine (NEJM) , provided the most impressive initial results